Apothederm Acne Clarifying Treatment Review
To see the photos better: clicking on photos will allow you to see an enlarged version of the photo.
I used the Apothederm Acne Clarifying Treatment every day, once a day, for two weeks. I still have a few red spots but I do see a significant decrease in acne. My problem area as of late has been my chin as you can see in the above photo. I don’t tend to have frequent breakouts, but during pregnancy I do. I’m about 4 weeks post-partum now and I think the acne clarifying treatment has helped clear up my acne and blemishes more quickly than if I had just not even bothered. The clarifying treatment does dry out my skin so moisturizer has been more of a necessity than before using it.
If you need a quick fix, then you’ll want to try the Apothederm Acne Clarifying Treatment. It costs $32.50 for 1oz, but you really don’t need to use a lot in one go. Just gently squirt one or two drops on your finger and it should be enough to cover your problem areas.
To the left you’ll see my “after” photo. My chin is still slightly red, but no more yucky pimples! Yay! The Apothederm Acne Clarifying Treatment actually reminds me of a prescription medication I use to have for acne. It works just as well in my opinion, and like the prescription medication, I bet you could wear makeup over it 5-10 minutes after application.
Benefits of Apothederm Acne Clarifying Treatment
- Reduces the appearance of blemishes
- Minimizes pore size
- Keeps skin balanced
- Fast absorbing
Acne Clarifying Treatment 1oz.
Gentle, Effective Results.
Our Acne Clarifying Treatment is a two-in-one problem solver to help eliminate breakouts and minimize pore size. This formula is packed with beta hydroxy acid and SmartPeptide® to help reduce the appearance of blemishes and future breakouts. Oil-free, fragrance free and dermatologist tested.
** I received one or more of the products mentioned above for free using Tomoson.com. Regardless, I only recommend products or services I use personally and believe will be good for my readers.